FDA Investigator David G Eng
David G Eng has inspections in 3 countries as of 14 Dec 2022. David G Eng has collaborated with a combinined 3084 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
36
Last Inspection Date:
14 Dec 2022
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Germany,
Austria
Co-Investigator(s):
Alexis R Ajello,
Alice A Blair,
Alicia K Mckinsey,
Alison A Nicoli,
Amir Alavi,
Andersoneric,
Andrew B Slarve,
Andrew E Kay,
Andrew Tadros,
Angel K Sandhu,
Angela D Wise,
Anh M Lac,
Anita Narula, PhD,
Annie H Lam,
Anthony E Keller, RPh,
Ashar P Parikh,
Barbara Janine Breithaupt,
Bo Chi, PhD,
Breena L D'ambrogi,
Bruce D Broidy,
Bruce H Mccullough,
Camacho,
Carl Lee,
Carolyn A Renshaw,
Carr,
Caryn M Mcnab,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Charles R Cote, RIC,
Cindy W Lewis,
Courtney R Bolton,
Courtney R Warren,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Cynthia L Ford,
Damon A Growl,
Daniel J Roberts,
David A Lum,
David J Gomes,
Denise Connelly,
Douglas A Campbell,
Douglas J Snyder,
Dr. Robert C Horan, MD,
Dustin P Tran,
Dustin R Abaonza,
Edmund F Mrak, Jr,
Eileen A Liu,
Ellen C Weisensel,
Elodie Xtong Lin,
Emal Wahab,
Erica R Pomeroy,
Gillenwater,
Gwyn G Dickinson,
Helen J Hamaoka,
Henry K Lau,
Huy T Pham,
Ismael Garibay,
Jacek Cieslak, PhD,
James C Lee, PharmD,
James C Yee,
James D Bridges,
James I Giefer,
James R Evans,
Janice Wai,
Jeanne A Young,
Jeffrey M Watson,
Jennifer Crumb,
Jennifer L Degroot,
Jennifer L Johnson,
Jennifer S King,
Jessica B Clark,
Joan T Briones,
Jolanna A Norton,
Jolene S Hedgecock,
Jose Alopez Rubet,
Joseph Kutze, PhD,
Kalavati Suvarna, PhD,
Karen D Phung,
Karla J Gibler,
Kathryn E King,
Keith O Webber, PhD,
Keith Webber, PhD,
Kevin A Gonzalez,
Kevin D Kallander,
Kevin P Foley,
Kim Lthomas Cruse,
Kouros Kangarli,
Kristin M Abaonza,
Lance M De Souza, MBA,
Larkin R Buckalew,
Laurie Graham,
Lawrence J Stringer,
LCDR Jennifer H Rhyu,
Lealand Lee,
Lee,
Leongc,
Linan Ha, PhD,
Linda F Murphy,
Lucila B Nwatu,
Luis A Solorzano,
Lydia S Chan,
Macropolk,
Margaret M Annes,
Maria Gutierrez Lugo, PhD,
Maria Joselopez Barragan, PhD,
Mariza M Jafary,
Mark E Chan,
Mark I Nakano,
Marshalette Edwards,
Marshalette O Edwards,
Mei Chiung J Huang,
Michael D Kawalek,
Michael Shanks, MS,
Michelle L Tripp,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Nabeela J Chaudhry,
Natalia Pripuzova, PhD,
Nicholas L Hunt,
Nympha V Florendo,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Patrick E Gainer,
Patrick L Wisor,
Patsy J Domingo,
Paul A Bonneau,
Paula A Trost,
Peter E Baker,
Phung,
Qing Joanna Zhou, PhD,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Riley C Graham,
Robert D Tollefsen,
Rumany C Penn, PharmD,
Ruth Moore, PhD,
Samina S Khan,
Sandra S Saniga,
Santos E Camara,
Scott N Lim,
Sean P Desbrow,
Sergio Chavez (NMI),
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Siobhan A Gallagher,
State Agency,
Stephanie A Slater, MS,
Stephen D Brown,
Stephen D Eich,
Steven C Himebaugh,
Steven M Galvez,
Stuart W Russell,
Susan M Jackson,
Susant Hadman,
Terrence Gee,
Terry A Hook, DPh,
Thea C Grome,
Thomas J Arista,
Thomas N Adjabeng,
Thomas W Gordon,
Tiffany Chao,
Timothy T Kapsala,
Travelle D Mason,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Vi T Au,
Vilmary Negron Rodriguez,
Wayne E Seifert,
Wayne L Jefferson,
Wen Jun Peng,
William J Weis,
William V Millar,
Xianghong Jing (Emily), PhD,
Yen Tso Kuo
David G Eng's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2016 | FDA 483 | Meditech Laboratories, Inc - Form 483, 2016-03-18 |
| November, 2016 | FDA 483 | Sandoz GmbH - Form 483, 2016-11-17 |
| November, 2015 | EIR | UCSF Radiopharmaceutical Facility - EIR, 2015-11-05 |
| August, 2015 | FDA 483 | Genentech, Inc. - Form 483, 2015-08-28 |
| November, 2015 | FDA 483 | UCSF Radiopharmaceutical Facility - Form 483, 2015-11-05 |
| May, 2016 | FDA 483 | Well Care Discount Pharmacy, LLC - Form 483, 2016-05-12 |
| July, 2015 | FDA 483 | PCP LV LLC dba Pinnacle Compounding Pharmacy - Form 483, 2015-07-31 |
| December, 2015 | FDA 483 | Acorn NMR Inc. - Form 483, 2015-12-11 |
| May, 2015 | FDA 483 | Alexza Pharmaceuticals, Inc. - Form 483, 2015-05-21 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more